TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive FDA Throws Up IND Roadblock, Then Refuses To Answer Investigator’s Letters About It February 6, 1976